Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 57.37 million shares for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed an increase of +25.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), CAPRICOR THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 65.7%.
- Historical annual values: Fiscal year 2025: 57.37 million shares | Fiscal year 2024: 45.58 million shares | Fiscal year 2023: 31.15 million shares | Fiscal year 2022: 25.24 million shares | Fiscal year 2021: 24.19 million shares | Fiscal year 2020: 20.58 million shares | Fiscal year 2019: 5.23 million shares | Fiscal year 2018: 3.14 million shares | Fiscal year 2017: 26.27 million shares | Fiscal year 2016: 21.40 million shares | Fiscal year 2015: 16.25 million shares | Fiscal year 2014: 11.71 million shares | Fiscal year 2013: 11.69 million shares | Fiscal year 2012: 10.35 million shares | Fiscal year 2011: 39.71 million shares | Fiscal year 2010: 34.63 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: